RE:RE:RE:market cap.Sometoast,
I admit that it may have been far fetched to have a $10 share price in such a short timeframe. However, if a commercial deal is signed by Merck and/or other pharmaceutical companies and REV technology becomes the new standard for vaccines, then what kind market cap would you foresee in Enwave's future? I'm willing to roll the dice. Yes, I realize that’s being optimistic, but I don’t think it’s unrealistic either.